Auto saved by Logseq

pages/STOP2030___Web.md

@@ -35,6 +35,10 @@
 			- Qualification at EMA for art. 58
 			- Safety of IVM up to 600μg/kg alone and in coformulation with albendazole
 			- Demonstrated efficacy agrainst T. trichiura in a pivotal trial in Sub-Saharan Africa
+			- No stopping rules were reached
+			- Safety was adequate
+			- Palatability results confirm adecuacy of size, taste and smell
+			- Superior efficacy against T. trichiura confirm
 		- ## Otros facts
 			- FDC of ivm/alb has the lowest level of investment risk of all candidates for Combination for STH treatment (STH Drug Combinations Expert Meeting, BMGF, April 2016)
 		- Investigadores principales de cada uno de los partners